secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2023-10-27T23:59:59+00:00
Accession:  0001558370-23-016946
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Coherus amends office lease, reduces space 42%, extends term to 2027
--------------------------------------------------------------------

- Lease reduced from ~47,789 sq ft to ~27,532 sq ft; 20,257 sq ft expire Dec 31, 2023.
- Remaining premises lease extended through Sep 30, 2027.
- Monthly base rent ~$0.17M from Jan-Sep 2024; annual rent ~$1.77M rising to ~$1.88M.
- Limited rent abatements on remaining premises before Sep 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023016946/0001558370-23-016946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023016946/chrs-20231024x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer